Baxter International (NYSE:BAX) Issues FY 2025 Earnings Guidance

Baxter International (NYSE:BAX) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 2.450-2.550 for the period, compared to the consensus EPS estimate of 2.460. The company issued revenue guidance of $11.2 billion-$11.3 billion, compared to the consensus revenue estimate of $11.2 billion. Baxter International also updated its Q1 2025 guidance to 0.470-0.500 EPS.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on BAX shares. StockNews.com lowered Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Stifel Nicolaus cut their price objective on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Finally, Citigroup lowered their target price on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $39.44.

Baxter International Stock Down 1.1 %

BAX stock opened at $30.86 on Thursday. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.43 and a quick ratio of 1.09. The firm’s fifty day simple moving average is $30.52 and its 200-day simple moving average is $34.15. Baxter International has a 12 month low of $28.33 and a 12 month high of $44.01. The company has a market capitalization of $15.75 billion, a P/E ratio of 154.28, a price-to-earnings-growth ratio of 9.83 and a beta of 0.61.

Baxter International (NYSE:BAX) last announced its quarterly earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.06. Baxter International had a return on equity of 18.30% and a net margin of 0.77%. As a group, equities research analysts forecast that Baxter International will post 1.83 earnings per share for the current year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 2.20%. The ex-dividend date is Friday, February 28th. Baxter International’s dividend payout ratio is currently 340.02%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.